[Insightec in PR Newswire] Insightec receives FDA approval to treat essential tremor patients’ second side, expanding total available market in United States

HAIFA, Israel & MIAMI, Dec. 20, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced it has received an additional FDA approval for treatment of essential tremor using its Exablate Neuro platform.

Read more here.